Winfield Associates’s Amgen AMGN Stock Holding History

Winfield Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-185	Closed	-$33K	–	144
2017 Q4	$33K	Sell	185 -200	-52%	-$35.4K	0.02%	231
2017 Q3	$71K	Hold	385	–	–	0.04%	169
2017 Q2	$66K	Hold	385	–	–	0.04%	170
2017 Q1	$63K	Buy	385 +50	+15%	+$8.31K	0.04%	171
2016 Q4	$49K	Buy	335 +10	+3%	+$1.5K	0.03%	181
2016 Q3	$54K	Buy	325 +5	+2%	+$846	0.03%	168
2016 Q2	$48K	Sell	320 -60	-16%	-$9.33K	0.03%	172
2016 Q1	$57K	Buy	380 +180	+90%	+$26.7K	0.04%	157
2015 Q4	$32K	Sell	200 -25	-11%	-$3.93K	0.02%	185
2015 Q3	$31K	Hold	225	–	–	0.02%	180
2015 Q2	$35K	Buy	225 +25	+13%	+$4K	0.02%	179
2015 Q1	$32K	Hold	200	–	–	0.02%	183
2014 Q4	$32K	Hold	200	–	–	0.02%	180
2014 Q3	$28K	Hold	200	–	–	0.02%	183
2014 Q2	$23K	Hold	200	–	–	0.02%	210
2014 Q1	$25K	Hold	200	–	–	0.02%	192
2013 Q4	$23K	Buy	+200	New	+$22.8K	0.02%	197

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Winfield Associates's AMGN Position: Q1 2018 in Review

Winfield Associates sold out of Amgen (AMGN) in Q1 2018, closing a stake of 185 shares — an estimated $33K sold.

Winfield Associates first reported a position in AMGN in Q4 2013 and held it in 17 quarters. The position peaked at $71K in Q3 2017. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

Winfield Associates reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
Winfield Associates sold 185 Amgen shares in Q1 2018, an estimated $33K.
Winfield Associates first reported a position in Amgen in Q4 2013 and held it in 17 quarters.
Winfield Associates's Amgen position peaked at $71K in Q3 2017.
1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.